FDA
-
-
-
-
-
-
-
Sientra Reports Record Second Quarter Financial and Operational Results
-
-
-
-
-
-
-
Sientra (SIEN) Announces FDA-Clearance of Next Generation AlloX2 Pro Tissue Expander
-
-
-
-
-
-
-
Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction
-
-
-
-
-
-
-
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Sientra Announces Proposed Public Offering
-
-
-
-
-
-
-
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel
-
-
-
-
-
-
-
Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022
-
251,890 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All